302 related articles for article (PubMed ID: 24493573)
1. Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.
Sarkadi AK; Taskó S; Csorba G; Tóth B; Erdős M; Maródi L
J Clin Immunol; 2014 Feb; 34(2):181-93. PubMed ID: 24493573
[TBL] [Abstract][Full Text] [Related]
2. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.
Kisand K; Bøe Wolff AS; Podkrajsek KT; Tserel L; Link M; Kisand KV; Ersvaer E; Perheentupa J; Erichsen MM; Bratanic N; Meloni A; Cetani F; Perniola R; Ergun-Longmire B; Maclaren N; Krohn KJ; Pura M; Schalke B; Ströbel P; Leite MI; Battelino T; Husebye ES; Peterson P; Willcox N; Meager A
J Exp Med; 2010 Feb; 207(2):299-308. PubMed ID: 20123959
[TBL] [Abstract][Full Text] [Related]
3. The heterogeneity of autoimmune polyendocrine syndrome type 1: Clinical features, new mutations and cytokine autoantibodies in a Brazilian cohort from tertiary care centers.
Weiler FG; Peterson P; Costa-Carvalho BT; de Barros Dorna M; Correia-Deur JE; Sader SL; Espíndola-Antunes D; Guerra-Junior G; Dias-da-Silva MR; Lazaretti-Castro M
Clin Immunol; 2018 Dec; 197():231-238. PubMed ID: 30287219
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I.
Puel A; Döffinger R; Natividad A; Chrabieh M; Barcenas-Morales G; Picard C; Cobat A; Ouachée-Chardin M; Toulon A; Bustamante J; Al-Muhsen S; Al-Owain M; Arkwright PD; Costigan C; McConnell V; Cant AJ; Abinun M; Polak M; Bougnères PF; Kumararatne D; Marodi L; Nahum A; Roifman C; Blanche S; Fischer A; Bodemer C; Abel L; Lilic D; Casanova JL
J Exp Med; 2010 Feb; 207(2):291-7. PubMed ID: 20123958
[TBL] [Abstract][Full Text] [Related]
5. Delay in the Diagnosis of APECED: A Case Report and Review of Literature from Iran.
Jamee M; Mahdaviani SA; Mansouri D; Azizi G; Joneidi N; Ghaffaripour H; Eskandarzade S; Ghaini M; Marjani M; Moniri A; Migaud M; Casanova J; Puel A; Velayati A
Immunol Invest; 2020 Apr; 49(3):299-306. PubMed ID: 31588815
[TBL] [Abstract][Full Text] [Related]
6. Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice.
Kärner J; Meager A; Laan M; Maslovskaja J; Pihlap M; Remm A; Juronen E; Wolff AS; Husebye ES; Podkrajšek KT; Bratanic N; Battelino T; Willcox N; Peterson P; Kisand K
Clin Exp Immunol; 2013 Mar; 171(3):263-72. PubMed ID: 23379432
[TBL] [Abstract][Full Text] [Related]
7. Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutanous candidiasis with or without APECED.
Ryan KR; Hong M; Arkwright PD; Gennery AR; Costigan C; Dominguez M; Denning D; McConnell V; Cant AJ; Abinun M; Spickett GP; Lilic D
Clin Exp Immunol; 2008 Dec; 154(3):406-14. PubMed ID: 19037923
[TBL] [Abstract][Full Text] [Related]
8. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
9. IL-6-specific autoantibodies among APECED and thymoma patients.
Kärner J; Pihlap M; Ranki A; Krohn K; Trebusak Podkrajsek K; Bratanic N; Battelino T; Willcox N; Peterson P; Kisand K
Immun Inflamm Dis; 2016 Jun; 4(2):235-243. PubMed ID: 27957331
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives.
Cervato S; Mariniello B; Lazzarotto F; Morlin L; Zanchetta R; Radetti G; De Luca F; Valenzise M; Giordano R; Rizzo D; Giordano C; Betterle C
Clin Endocrinol (Oxf); 2009 Mar; 70(3):421-8. PubMed ID: 18616706
[TBL] [Abstract][Full Text] [Related]
11. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.
Wolff AS; Sarkadi AK; Maródi L; Kärner J; Orlova E; Oftedal BE; Kisand K; Oláh E; Meloni A; Myhre AG; Husebye ES; Motaghedi R; Perheentupa J; Peterson P; Willcox N; Meager A
J Clin Immunol; 2013 Nov; 33(8):1341-8. PubMed ID: 24158785
[TBL] [Abstract][Full Text] [Related]
12. Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody.
Yamazaki Y; Yamada M; Kawai T; Morio T; Onodera M; Ueki M; Watanabe N; Takada H; Takezaki S; Chida N; Kobayashi I; Ariga T
J Immunol; 2014 Nov; 193(10):4880-7. PubMed ID: 25288569
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis.
Kisand K; Peterson P
Curr Opin Pediatr; 2013 Dec; 25(6):715-21. PubMed ID: 24240291
[TBL] [Abstract][Full Text] [Related]
14. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
Collins SM; Dominguez M; Ilmarinen T; Costigan C; Irvine AD
Br J Dermatol; 2006 Jun; 154(6):1088-93. PubMed ID: 16704638
[TBL] [Abstract][Full Text] [Related]
15. Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1.
Humbert L; Cornu M; Proust-Lemoine E; Bayry J; Wemeau JL; Vantyghem MC; Sendid B
Front Immunol; 2018; 9():2570. PubMed ID: 30510552
[TBL] [Abstract][Full Text] [Related]
16. Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
Ng WF; von Delwig A; Carmichael AJ; Arkwright PD; Abinun M; Cant AJ; Jolles S; Lilic D
J Allergy Clin Immunol; 2010 Nov; 126(5):1006-15, 1015.e1-4. PubMed ID: 20934207
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy in Calabria: clinical, immunological and genetic patterns.
Betterle C; Ghizzoni L; Cassio A; Baronio F; Cervato S; Garelli S; Barbi E; Tonini G
J Endocrinol Invest; 2012 Nov; 35(10):877-81. PubMed ID: 22104652
[TBL] [Abstract][Full Text] [Related]
18. Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model.
Ahlgren KM; Moretti S; Lundgren BA; Karlsson I; Ahlin E; Norling A; Hallgren A; Perheentupa J; Gustafsson J; Rorsman F; Crewther PE; Rönnelid J; Bensing S; Scott HS; Kämpe O; Romani L; Lobell A
Eur J Immunol; 2011 Jan; 41(1):235-45. PubMed ID: 21182094
[TBL] [Abstract][Full Text] [Related]
19. IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model.
Bichele R; Kärner J; Truusalu K; Smidt I; Mändar R; Conti HR; Gaffen SL; Peterson P; Laan M; Kisand K
Eur J Immunol; 2018 Mar; 48(3):464-470. PubMed ID: 29150834
[TBL] [Abstract][Full Text] [Related]
20. Anti-cytokine autoantibodies explain some chronic mucocutaneous candidiasis.
Browne SK; Holland SM
Immunol Cell Biol; 2010 Aug; 88(6):614-5. PubMed ID: 20548324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
